The rs2292239 polymorphism in ERBB3 gene is associated with risk for type 1 diabetes mellitus in a Brazilian population.

[1]  J. Ilonen,et al.  Primary islet autoantibody at initial seroconversion and autoantibodies at diagnosis of type 1 diabetes as markers of disease heterogeneity , 2018, Pediatric diabetes.

[2]  Cristine Dieter,et al.  GLIS3 rs7020673 and rs10758593 polymorphisms interact in the susceptibility for type 1 diabetes mellitus , 2017, Acta Diabetologica.

[3]  L. Canani,et al.  Polymorphisms in genes encoding miR-155 and miR-146a are associated with protection to type 1 diabetes mellitus , 2017, Acta Diabetologica.

[4]  Å. Lernmark,et al.  Genetic risk factors for type 1 diabetes , 2016, The Lancet.

[5]  W. Lu,et al.  ERBB3-rs2292239 as primary type 1 diabetes association locus among non-HLA genes in Chinese , 2016, Meta gene.

[6]  F. Pociot,et al.  The genetic and regulatory architecture of ERBB3-type 1 diabetes susceptibility locus , 2016, Molecular and Cellular Endocrinology.

[7]  J. Noble.  Immunogenetics of type 1 diabetes: A comprehensive review. , 2015, Journal of autoimmunity.

[8]  N. Breslow,et al.  Non-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies , 2015, Genes and Immunity.

[9]  J. Ilonen,et al.  Non-HLA gene effects on the disease process of type 1 diabetes: From HLA susceptibility to overt disease. , 2015, Journal of autoimmunity.

[10]  Xingbin Wang,et al.  Association of 32 type 1 diabetes risk loci in Pakistani patients. , 2015, Diabetes research and clinical practice.

[11]  Manolis Kellis,et al.  Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers , 2015, Nature Genetics.

[12]  J. Ilonen,et al.  Role of Type 1 Diabetes–Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study , 2014, Diabetes.

[13]  Fabian J Theis,et al.  Feature ranking of type 1 diabetes susceptibility genes improves prediction of type 1 diabetes , 2014, Diabetologia.

[14]  C. Wijmenga,et al.  Improving prediction of type 1 diabetes by testing non‐HLA genetic variants in addition to HLA markers , 2014, Pediatric diabetes.

[15]  L. Canani,et al.  Polymorphisms in the TLR3 gene are associated with risk for type 1 diabetes mellitus. , 2014, European Journal of Endocrinology.

[16]  W. Dai,et al.  CCCTC‐binding factor mediates effects of glucose on beta cell survival , 2014, Cell proliferation.

[17]  Qin Li,et al.  The function of human epidermal growth factor receptor-3 and its role in tumors (Review). , 2013, Oncology reports.

[18]  H. Hakonarson,et al.  Genes Involved in Type 1 Diabetes: An Update , 2013, Genes.

[19]  F. Pociot,et al.  Complex Multi-Block Analysis Identifies New Immunologic and Genetic Disease Progression Patterns Associated with the Residual β-Cell Function 1 Year after Diagnosis of Type 1 Diabetes , 2013, PloS one.

[20]  A. Ziegler,et al.  Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children , 2013, Diabetologia.

[21]  G. Morahan,et al.  Definition of High-Risk Type 1 Diabetes HLA-DR and HLA-DQ Types Using Only Three Single Nucleotide Polymorphisms , 2013, Diabetes.

[22]  Fabian J Theis,et al.  A strategy for combining minor genetic susceptibility genes to improve prediction of disease in type 1 diabetes , 2012, Genes and Immunity.

[23]  M. McCarthy,et al.  The Human Pancreatic Islet Transcriptome: Expression of Candidate Genes for Type 1 Diabetes and the Impact of Pro-Inflammatory Cytokines , 2012, PLoS genetics.

[24]  T. Maruyama,et al.  Analysis of the HLA and non‐HLA susceptibility loci in Japanese type 1 diabetes , 2011, Diabetes/metabolism research and reviews.

[25]  Ira M. Hall,et al.  Evidence for two independent associations with type 1 diabetes at the 12q13 locus , 2011, Genes and Immunity.

[26]  E. Urcelay,et al.  Polymorphisms in chromosome region 12q13 and their influence on age at onset of type 1 diabetes , 2011, Diabetologia.

[27]  J. She,et al.  Association between type 1 diabetes and GWAS SNPs in the southeast US Caucasian population , 2011, Genes and Immunity.

[28]  A. Steck,et al.  Genetics of type 1 diabetes. , 2011, Clinical chemistry.

[29]  J. She,et al.  Genetically Dependent ERBB3 Expression Modulates Antigen Presenting Cell Function and Type 1 Diabetes Risk , 2010, PloS one.

[30]  V. Nosikov,et al.  Association of the polymorphisms of the ERBB3 and SH2B3 genes with type 1 diabetes , 2010, Molecular Biology.

[31]  J. Baselga,et al.  Novel anticancer targets: revisiting ERBB2 and discovering ERBB3 , 2009, Nature Reviews Cancer.

[32]  Helen Schuilenburg,et al.  Genome-wide association study and meta-analysis finds over 40 loci affect risk of type 1 diabetes , 2009, Nature Genetics.

[33]  J. Ioannidis,et al.  STrengthening the REporting of Genetic Association Studies (STREGA)— An Extension of the STROBE Statement , 2009, Annals of Internal Medicine.

[34]  Vincent Plagnol,et al.  Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci , 2008, Nature Genetics.

[35]  J. Lau,et al.  Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. , 2008, Journal of clinical epidemiology.

[36]  Antony W Burgess,et al.  EGFR family: Structure physiology signalling and therapeutic targets† , 2008, Growth factors.

[37]  Matthias Egger,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies , 2007, PLoS medicine.

[38]  R. A. Bailey,et al.  Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes , 2007, Nature Genetics.

[39]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[40]  Andrzej S Krolewski,et al.  Genetics of Kidneys in Diabetes (GoKinD) study: a genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes. , 2006, Journal of the American Society of Nephrology : JASN.

[41]  J. Thompson,et al.  The choice of a genetic model in the meta-analysis of molecular association studies. , 2005, International journal of epidemiology.

[42]  N. Sarvetnick,et al.  Expression of ErbB receptors during pancreatic islet development and regrowth. , 2000, The Journal of endocrinology.

[43]  BOULIN,et al.  Classification and Diagnosis of Diabetes. , 2022, Primary care.

[44]  Fabian J Theis,et al.  A strategy to find gene combinations that identify children who progress rapidly to type 1 diabetes after islet autoantibody seroconversion , 2013, Acta Diabetologica.

[45]  M. V. von Herrath,et al.  Type 1 diabetes: etiology, immunology, and therapeutic strategies. , 2011, Physiological reviews.

[46]  T. Maruyama,et al.  Association of type 1 diabetes with two Loci on 12q13 and 16p13 and the influence coexisting thyroid autoimmunity in Japanese. , 2009, The Journal of clinical endocrinology and metabolism.